CN Patent

CN104583192B — 适合于线粒体复合体-1检出的化合物

Assigned to Hamamatsu Photonics KK · Expires 2016-10-12 · 10y expired

What this patent protects

本发明提供以式(1‑0)表示的化合物。 (式(1‑0)中，R表示‑O(CH 2 ) n ‑、‑O(CH 2 ) n OC 2 H 4 ‑、‑CH 2 O(CH 2 ) n ‑或‑CH 2 O(CH 2 ) n OC 2 H 4 ‑，n表示1～5的整数，Q 1 表示F或‑OCH 3 )。

USPTO Abstract

本发明提供以式(1‑0)表示的化合物。 (式(1‑0)中，R表示‑O(CH 2 ) n ‑、‑O(CH 2 ) n OC 2 H 4 ‑、‑CH 2 O(CH 2 ) n ‑或‑CH 2 O(CH 2 ) n OC 2 H 4 ‑，n表示1～5的整数，Q 1 表示F或‑OCH 3 )。

Drugs covered by this patent

Patent Metadata

Patent number: CN104583192B
Jurisdiction: CN
Classification: —
Expires: 2016-10-12
Drug substance claim: No
Drug product claim: No
Assignee: Hamamatsu Photonics KK
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.